CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Earnings & Estimates
NASDAQ:CLOV - US18914F1030 - Common Stock
2.635 USD
+0.01 (+0.57%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.477B 136.19% | 1.261B -63.74% | 1.371B 8.77% | 1.918B 39.88% | 2.437B 27.06% | 2.775B 13.87% | 3.299B 18.88% | 3.797B 15.10% | 4.445B 17.07% | 5.757B 29.52% | |
| EBITDA YoY % growth | -369.71M 41.85% | -177.054M 52.11% | -44.13M 75.08% | 56.767M 228.64% | 81.471M 43.52% | 131.04M 60.84% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -370.9M 41.77% | -179.563M 51.59% | -45.461M 74.68% | -32.868M 27.70% | -50.535M -53.75% | 19.705M 138.99% | 133.26M 576.28% | 199.89M 50.00% | 288.95M 44.55% | 359.8M 24.52% | |
| Operating Margin | -10.67% | -14.24% | -3.32% | -1.71% | -2.07% | 0.71% | 4.04% | 5.26% | 6.50% | 6.25% | |
| EPS YoY % growth | -0.74 41.52% | -0.44 40.94% | -0.09 79.55% | -0.12 -36.00% | -0.10 20.83% | -0.02 84.21% | 0.29 1,966.67% | 0.31 7.14% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 -78.50% | -0.06 -40.25% | 0.01 | 0.00 83.02% | -0.02 42.86% | -0.06 -15.15% | 0.03 200.00% | 0.03 1,000.90% | 0.01 150.00% | -0.05 21.05% |
| Revenue Q2Q % growth | 476.52M 43.97% | 482.33M 43.14% | 606.87M 31.26% | 614.09M 28.57% | 604.51M 26.86% | 610.75M 26.62% | 655.13M 7.95% | 659.26M 7.36% | 636.63M 5.31% | 640.55M 4.88% |
| EBITDA Q2Q % growth | 11.602M 239.18% | 1.028M 105.11% | 35.781M 4,528.34% | 29.562M 404.79% | 23.162M 99.64% | 4.17M 305.64% | 46.685M 30.47% | 43.013M 45.50% | 33.334M 43.92% | 1.489M -64.29% |
| EBIT Q2Q % growth | -11.478M -23.12% | -23.377M -9.00% | 2.914M 328.73% | -4.405M 58.28% | -16.82M -46.54% | -32.462M -38.86% | 46.288M 1,488.47% | 42.616M 1,067.47% | 32.936M 295.82% | 1.081M 103.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.02 -300.00% | -0.03 | 0.01 | 28.70% |
| Q1 2025 Q2Q % growth | 0.00 100.00% | -0.06 | 0.06 | 100.00% |
| Q4 2024 Q2Q % growth | -0.04 71.43% | -0.07 | 0.03 | 39.67% |
| Q3 2024 Q2Q % growth | -0.02 77.78% | -0.04 | 0.02 | 50.98% |
| Q2 2024 Q2Q % growth | 0.01 116.67% | -0.05 | 0.06 | 120.14% |
| Q1 2024 Q2Q % growth | -0.04 73.33% | -0.07 | 0.03 | 45.78% |
| Q4 2023 Q2Q % growth | -0.14 20.00% | -0.14 | 0.00 | 1.49% |
| Q3 2023 Q2Q % growth | -0.09 43.75% | -0.11 | 0.02 | 16.50% |
| Q2 2023 Q2Q % growth | -0.06 72.73% | -0.15 | 0.09 | 60.89% |
| Q1 2023 Q2Q % growth | -0.15 21.05% | -0.18 | 0.03 | 16.35% |
| Q4 2022 Q2Q % growth | -0.18 38.38% | -0.26 | 0.09 | 32.77% |
| Q3 2022 Q2Q % growth | -0.16 -100.00% | -0.24 | 0.08 | 34.37% |
| Q2 2022 Q2Q % growth | -0.22 71.79% | -0.21 | -0.01 | -4.60% |
| Q1 2022 Q2Q % growth | -0.19 -46.15% | -0.28 | 0.09 | 31.87% |
| Q4 2021 Q2Q % growth | -0.28 -42.00% | -0.27 | -0.02 | -5.80% |
| Q3 2021 Q2Q % growth | -0.08 | -0.23 | 0.15 | 65.64% |
| Q2 2021 Q2Q % growth | -0.78 | -0.14 | -0.64 | -465.07% |
| Q1 2021 Q2Q % growth | -0.13 | -0.11 | -0.02 | -15.16% |
| Q4 2020 Q2Q % growth | -0.20 | -0.86 | 0.66 | 76.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 477.62M 34.07% | 477.66M | -40K | -0.01% |
| Q1 2025 Q2Q % growth | 462.331M 33.27% | 489.07M | -26.739M | -5.47% |
| Q4 2024 Q2Q % growth | 336.963M -33.96% | 390.2M | -53.237M | -13.64% |
| Q3 2024 Q2Q % growth | 330.986M -31.34% | 353.2M | -22.214M | -6.29% |
| Q2 2024 Q2Q % growth | 356.26M -30.64% | 345.54M | 10.72M | 3.10% |
| Q1 2024 Q2Q % growth | 346.922M -34.27% | 327.65M | 19.272M | 5.88% |
| Q4 2023 Q2Q % growth | 510.251M -43.23% | 489.86M | 20.391M | 4.16% |
| Q3 2023 Q2Q % growth | 482.066M -43.74% | 504.49M | -22.424M | -4.44% |
| Q2 2023 Q2Q % growth | 513.628M -39.34% | 500.64M | 12.988M | 2.59% |
| Q1 2023 Q2Q % growth | 527.775M -39.64% | 508.71M | 19.065M | 3.75% |
| Q4 2022 Q2Q % growth | 898.8M 108.06% | 801.09M | 97.71M | 12.20% |
| Q3 2022 Q2Q % growth | 856.8M 100.56% | 815.45M | 41.35M | 5.07% |
| Q2 2022 Q2Q % growth | 846.7M 105.26% | 830.91M | 15.79M | 1.90% |
| Q1 2022 Q2Q % growth | 874.4M 336.55% | 803.16M | 71.24M | 8.87% |
| Q4 2021 Q2Q % growth | 432M | 416.3M | 15.7M | 3.77% |
| Q3 2021 Q2Q % growth | 427.2M | 421.36M | 5.84M | 1.39% |
| Q2 2021 Q2Q % growth | 412.5M | 209.49M | 203.01M | 96.91% |
| Q1 2021 Q2Q % growth | 200.3M | 196.42M | 3.88M | 1.98% |
| Q4 2020 Q2Q % growth | 170.3M | -170.3M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.69% | -40% | 4% | 4% |
| Revenue | 0.05% | 10.84% | 0.95% | 0.95% |